Showroom

(74)

Active Pharmaceutical Ingredients (APIs) are the active components of drugs. Valsartan manages hypertension and heart failure (C24H29N5O3), Calcitriol regulates calcium (C27H44O3), Milnacipran treats fibromyalgia and depression (C15H23N). Formulation mixes APIs with excipients for various doses. Testing ensures purity and potency. Stringent quality control ensures safety and efficacy in pharmaceutical production.

Valsartan API

Salbutamol Sulphate

levosalbutamol Sulphate API

Molnupiravir API

Milnacipran HCL API

Calcitriol API

Bupivacaine API

Chemical API

Minoxidil API

Chemical API

Ondansetron Hydrochloride

Moxifloxacin hydrochloride

...More

(3)

API Under Development

APIs under development include Cetrizine Hydrochloride IP-BP-USP and Empagliflozin IP-BP-USP. Cetrizine, an antihistamine (C21H25ClN2O3), and Empagliflozin, for type 2 diabetes (C23H27ClO7), are odorless powders, stored at room temperature. Formulation integrates them with excipients for various applications. Testing ensures purity and efficacy, tailoring their effects to therapeutic goals for commercial use post-development.

Sitagliptin Phosphate IP-BP-USP Monohydrate

Cetrizine Hydrochloride IP-BP-USP

Empagliflozin IP-BP-USP

...More

(11)

API Intermediates

API Intermediates are compounds used in synthesizing Active Pharmaceutical Ingredients (APIs). Examples include 5-Bromo-2-Chlorobenzoic Acid and 3-Amino-1-Adamantanol (C7H4BrClO2 and C10H17NO, respectively). They undergo rigorous testing for purity. These intermediates enhance efficiency and yield in API synthesis, indirectly influencing the final therapeutic properties. They are crucial in creating diverse and effective medications.